Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Psychopharmacology (Oxford, England)|July 1, 2023
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptomsPatrick D Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 6, 2021
Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophreniaMohini Ranganathan, Mohamed Rahman, Suhas Ganesh, et al.
Psychopharmacology|June 13, 2019
Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humansMohini Ranganathan, Joao P De Aquino, Jose A Cortes-Briones, et al.
The International Journal of Neuropsychopharmacology|January 17, 2012
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humansMohini Ranganathan, Michelle Carbuto, Gabriel Braley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 21, 2012
The effect of chronic cannabinoids on broadband EEG neural oscillations in humansPatrick D Skosnik, Deepak C D'Souza, Adam B Steinmetz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 3, 2010
Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependenceJohn H Krystal, Ismene L Petrakis, Diana Limoncelli, et al.
The Journal of Clinical Psychiatry|September 7, 2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled studyJohn M Kane, Deepak C D'Souza, Ashwin A Patkar, et al.
Schizophrenia Research|December 11, 2012
Efficacy of pimozide augmentation for clozapine partial responders with schizophreniaHandan Gunduz-Bruce, Stephen Oliver, Ralitza Gueorguieva, et al.
Psychopharmacology|July 8, 2020
In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteersEmmanuelle A D Schindler, Ashley M Schnakenberg Martin, R Andrew Sewell, et al.
Journal of the Neurological Sciences|April 6, 2024
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Pageof 4